Apogee Therapeutics IPO Indicating $22.10 On 266K Shares; IPO Priced At $17/Share On 17.65M Shares
Portfolio Pulse from Happy Mohamed
Apogee Therapeutics has priced its IPO at $17 per share, with 17.65 million shares being offered. The IPO is currently indicating $22.10 on 266K shares.
July 14, 2023 | 2:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apogee Therapeutics' IPO is indicating a higher price than initially set, suggesting strong demand for the stock.
The IPO price indication of $22.10, which is higher than the initial price of $17, suggests strong demand for Apogee Therapeutics' shares. This could lead to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100